DOCSLIB.ORG

INTELLIGENT MEDICINE the Wings of Global Health

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
INTELLIGENT MEDICINE the Wings of Global Health INTELLIGENT MEDICINE The Wings of Global Health AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Editorial Board p.2 • Guide for Authors p.6 ISSN: 2667-1026 DESCRIPTION . Intelligent Medicine is an open access, peer-reviewed journal sponsored and owned by the Chinese Medical Association and designated to publish high-quality research and application in the field of medical-industrial crossover concerning the internet technology, artificial intelligence (AI), data science, medical information, and intelligent devices in the clinical medicine, biomedicine, and public health. Intelligent Medicine appreciates the innovation, pioneering, science, and application, encourages the unique perspectives and suggestions. The topics focus on the computer and data science enabled intelligent medicine, including while not limited to the clinical decision making, computer-assisted surgery, telemedicine, drug development, image analysis and computation, and health management. The journal sets academic columns according to the different disciplines and hotspots. Article types include Research Article: These articles are expected to be original, innovative, and significant, including medical and algorithmic research. The real-world medical research rules and clinical assessment of the usefulness and reliability are recommended for those medical research. The full text is about 6,000 words, with structured abstract of 300 words including Background, Methods, Results, and Conclusion. Editorial: Written by the Editor-in-Chief, Associate Editors, editorial board members, or prestigious invited scientists and policy makers on a broad range of topics from science to policy. Review: Extensive reviews of the recent progress in specific areas of science, involving historical reviews, recent advances made by scientists internationally, and perspective for future development; the full text is about 5,000~6,000 words. Descriptive abstract is needed, about 200~300 words. Perspective & Comments: Personal opinions, hypotheses, or considering controversial issues are welcome. The length of text should be about 1500~2000 words and the abstract about 250 words with 10 or fewer references. Research Highlight: Succinct summaries and comments on a recent research achievement, with emphasis on the contributions of Chinese scientists.Guideline & Standard: Official recommendations from professional organizations on issues related to clinical practice, healthcare delivery, and data management in intelligent medicine. Guidelines that meet the standards (http://www.equator-network.org/) will fare more favorably than those that do not. Ethical, Legal, and Social Implications: Explore the ethical issues involved in intelligent medicine. Abstract, keywords, and references are needed. Case Report: The text is limited to no more than 1000 words without abstract and key words, 5 or fewer references, maximum of 1 table or figure. Declaration of patient consent must be stated if the paper contains patient information. Historical Moment: Describes some specific aspects, life, and stories in the history of scientific contributions and applications. Letter: Letter to editors. They should preferably be related to articles previously published in this journal. The text is limited to no more than 500 words without abstract AUTHOR INFORMATION PACK 3 Oct 2021 www.elsevier.com/locate/imed 1 and key words, 5 or fewer references, maximum of one table or one figure. Declaration of patient consent must be stated if the article contains patient information. EDITORIAL BOARD . Editor-in-Chief Jiahong Dong, Beijing Tsinghua Changgung Hospital, Beijing, China Liver transplantation, Precision hepatobiliary surgery Associate Editor Qionghai Dai, Tsinghua University School of Information Science and Technology, Beijing, China Artificial Intelligence Jia-Hong Gao, Peking University, Academy for Advanced Interdisciplinary Studies, Magnetic Resonance Imaging Research Center, Beijing, China Nuclear technology and Application Jacques Marescaux, Research Institute Against Digestive Cancer, Strasbourg, France Artificial Intelligence Guang Ning, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Endocrinology Björn Schuller, Imperial College London, London, United Kingdom Speech Processing, Affective Computing, Deep Learning, Artificial Intelligence Dinggang Shen, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America Medical AI, Medical image analysis, computer vision, and pattern recognition, Radiology Jie Tian, Chinese Academy of Sciences Institute of Automation, Beijing, China Molecular imaging Wei Tian, Beijing Jishuitan Hospital, Beijing, China Orthopaedics Tao Wu, Shanghai University of Medicine and Health Sciences, Shanghai, China Artificial Intelligence, Hospital management Xifeng Wu, Zhejiang University School of Public Health, Hangzhou, China Molecular epidemiology, Health data Editorial Board Members Diseases & Models Jiebo Luo, University of Rochester, Rochester, New York, United States of America Computer algorithm Yizhou Yu, Beijing Deepwise Company Limited, Beijing, China Medical Image Analysis, Artificial Intelligence Shaohua Zhou, Institute of Computing Technology Chinese Academy of Sciences, Beijing, China Medical Imaging Ethics Xinqing Zhang, Chinese Academy of Medical Sciences & Peking Union Medical College School of Humanities and Social Sciences, Beijing, China Bioethics Genome Medicine Taijiao Jiang, Suzhou Institute of Systems Medicine, Suzhou, China Biomedical engineering Nan Wu, Peking Union Medical College Hospital, Beijing, China Orthopaedics, Genetics, Big data, Artificial Intelligence Health Data Luzhao Feng, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China Public Health Yuanqing Ye, Zhejiang University Library, Hangzhou, China Big data and Health Science Image Computing & Digital Medicine Chunming Li, University of Electronic Science and Technology of China, Chengdu, China Digital medicine Tianming Liu, University of Georgia, Athens, Georgia, United States of America Artificial intelligence AUTHOR INFORMATION PACK 3 Oct 2021 www.elsevier.com/locate/imed 2 Intelligent Cardiology Zhongzhao Teng, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom Cardiovascular imaging, Atherosclerosis, Stroke, Aneurysm, Biomechanics Longjiang Zhang, General Hospital of Eastern Theater Command, Nanjing, China Medical imaging Intelligent Dermatology Yong Cui, China-Japan Friendship Hospital, Beijing, China Dermatology Yi Zhao, Beijing Tsinghua Changgung Hospital, Beijing, China Dermatology Intelligent Endoscope Pinghong Zhou, Zhongshan Hospital, Fudan University, Shanghai, China Endoscopic therapy Intelligent Gastroenterology Yun Lu, The Affiliated Hospital of Qingdao University, Qingdao, China Digital medicine Intelligent Hepatobiliary Surgery Yu Fan Cheng, Chinese Taiwan Kaohsiung Changgeng Memorial Hospital, Kaohsiung, China Medical Imaging Intelligent Health Service System Bin Yang, Tsinghua University, Beijing, China Artificial intelligence Yi Lyu, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China Liver transplantation Intelligent Medicine & Evidence-based Medicine Yaolong Chen, Lanzhou University, Lanzhou, China Evidence-based medicine, Clinical practice guidelines, Reporting guideline, GRADE Intelligent Neuropsychiatry Xingang Li, Qilu Hospital, Shandong University, Jinan, China Neurosurgery Ying Mao, Huashan Hospital Fudan University, Shanghai, China Neurosurgery Gang Zhao, The Fourth Military Medical University, Xian, China Neurology Intelligent Ophthalmology Haotian Lin, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China Ophthalmology Yaxing Wang, Beijing Tongren Hospital, Capital Medical University, Beijing, China Ophthalmology Intelligent Otolaryngology Zhenchang Wang, Beijing Friendship Hospital, Capital Medical University, Beijing, China Head and neck radiology Jingying Ye, Beijing Tsinghua Changgung Hospital, Beijing, China Otorhinolaryngology Head and Neck Surgery Intelligent Pathology Hong Bu, West China Hospital of Sichuan University, Chengdu, China Pathology Limin Yu, Beaumont Health, Royal Oak, Michigan, United States of America AI and machine learning in medicine Intelligent Traumatology Baoguo Jiang, Peking University People's Hospital, Department of Orthopaedics, Beijing, China Orthopaedics AUTHOR INFORMATION PACK 3 Oct 2021 www.elsevier.com/locate/imed 3 Intelligent Ultrasound Medicine Ping Liang, Chinese PLA General Hospital, Beijing, China Interventional ultrasound Dong Ni, Shenzhen University, Shenzhen, China Biomedical engineering Rehabilitation Medicine Paolo Milia, University of Perugia, Perugia, Italy Neurology, Rehabilitation robot Robotics and Minimally Invasive Surgery Hecheng Li, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China Thoracic Surgery Xinghuan Wang, Zhongnan Hospital of Wuhan University, Wuhan, China Urology Surgery WHO Digital Report Yanwu Xu, Baidu (Beijing) Company Limited, Beijing, China Artificial intelligence, Medical Imaging, Ocular Imaging Others Yang Chen, Southeast University, Nanjing, China Computer Science, Deep learning, Image restoration, Image reconstruction, segmentation Wen Yuan Chung, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom Hepatobiliary and pancreatic surgery, Artificial Intelligent, Early diagnosis of pancreatic cancer, Ex vivo normothermic organ perfusion David Dagang Feng,
Load more

Recommended publications
  • VISPA: a Computational Pipeline for the Identification and Analysis Of
    Calabria et al. Genome Medicine 2014, 6:67 http://genomemedicine.com/content/6/9/67 SOFTWARE Open Access VISPA: a computational pipeline for the identification and analysis of genomic vector integration sites Andrea Calabria1†, Simone Leo2,3†, Fabrizio Benedicenti1, Daniela Cesana1, Giulio Spinozzi1,4, Massimilano Orsini2, Stefania Merella5, Elia Stupka5, Gianluigi Zanetti2 and Eugenio Montini1* Abstract The analysis of the genomic distribution of viral vector genomic integration sites is a key step in hematopoietic stem cell-based gene therapy applications, allowing to assess both the safety and the efficacy of the treatment and to study the basic aspects of hematopoiesis and stem cell biology. Identifying vector integration sites requires ad-hoc bioinformatics tools with stringent requirements in terms of computational efficiency, flexibility, and usability. We developed VISPA (Vector Integration Site Parallel Analysis), a pipeline for automated integration site identification and annotation based on a distributed environment with a simple Galaxy web interface. VISPA was successfully used for the bioinformatics analysis of the follow-up of two lentiviral vector-based hematopoietic stem-cell gene therapy clinical trials. Our pipeline provides a reliable and efficient tool to assess the safety and efficacy of integrating vectors in clinical settings. Background the proximity of the vector’sintegrationsite(IS),a Viral vectors, due to their ability to permanently integrate phenomenon known as insertional mutagenesis (IM) in a target genome, are used to achieve the stable genetic [1,9-12]. The identification of ISs on leukemic cells from modification of therapeutically relevant cells and their GT patients and preclinical models allowed identifying progeny. In particular, γ-retroviral (γ-RVs) and lentiviral the causes of IM and tracking the evolution of the (LVs) vectors are the preferred choice for hematopoietic malignant clone over time [11-16].
    [Show full text]
  • Developing and Implementing an Institute-Wide Data Sharing Policy Stephanie OM Dyke and Tim JP Hubbard*
    Dyke and Hubbard Genome Medicine 2011, 3:60 http://genomemedicine.com/content/3/9/60 CORRESPONDENCE Developing and implementing an institute-wide data sharing policy Stephanie OM Dyke and Tim JP Hubbard* Abstract HapMap Project [7], also decided to follow HGP prac- tices and to share data publicly as a resource for the The Wellcome Trust Sanger Institute has a strong research community before academic publications des- reputation for prepublication data sharing as a result crib ing analyses of the data sets had been prepared of its policy of rapid release of genome sequence (referred to as prepublication data sharing). data and particularly through its contribution to the Following the success of the first phase of the HGP [8] Human Genome Project. The practicalities of broad and of these other projects, the principles of rapid data data sharing remain largely uncharted, especially to release were reaffirmed and endorsed more widely at a cover the wide range of data types currently produced meeting of genomics funders, scientists, public archives by genomic studies and to adequately address and publishers in Fort Lauderdale in 2003 [9]. Meanwhile, ethical issues. This paper describes the processes the Organisation for Economic Co-operation and and challenges involved in implementing a data Develop ment (OECD) Committee on Scientific and sharing policy on an institute-wide scale. This includes Tech nology Policy had established a working group on questions of governance, practical aspects of applying issues of access to research information [10,11], which principles to diverse experimental contexts, building led to a Declaration on access to research data from enabling systems and infrastructure, incentives and public funding [12], and later to a set of OECD guidelines collaborative issues.
    [Show full text]
  • Cancer Genome Interpreter Annotates the Biological and Clinical Relevance of Tumor Alterations David Tamborero1,2, Carlota Rubio-Perez1, Jordi Deu-Pons1,2, Michael P
    Tamborero et al. Genome Medicine (2018) 10:25 https://doi.org/10.1186/s13073-018-0531-8 DATABASE Open Access Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations David Tamborero1,2, Carlota Rubio-Perez1, Jordi Deu-Pons1,2, Michael P. Schroeder1,3, Ana Vivancos4, Ana Rovira5,6, Ignasi Tusquets5,6,7, Joan Albanell5,6,8, Jordi Rodon4, Josep Tabernero4, Carmen de Torres9, Rodrigo Dienstmann4, Abel Gonzalez-Perez1,2 and Nuria Lopez-Bigas1,2,10* Abstract While tumor genome sequencing has become widely available in clinical and research settings, the interpretation of tumor somatic variants remains an important bottleneck. Here we present the Cancer Genome Interpreter, a versatile platform that automates the interpretation of newly sequenced cancer genomes, annotating the potential of alterations detected in tumors to act as drivers and their possible effect on treatment response. The results are organized in different levels of evidence according to current knowledge, which we envision can support a broad range of oncology use cases. The resource is publicly available at http://www.cancergenomeinterpreter.org. Background to systematically identify genes involved in tumorigen- The accumulation of so-called “driver” genomic alter- esis through the detection of signals of positive selection ations confers on cells tumorigenic capabilities [1]. in their alteration patterns across tumors of some two Thousands of tumor genomes are sequenced around the dozen malignancies [3–6]. However, many of the som- world every year for both research and clinical purposes. atic variants detected in tumors, even those in cancer In some cases the whole genome is sequenced while in genes, still have uncertain significance and thus it is not others the focus is on the exome or a panel of selected clear whether or not they are relevant for tumorigenesis.
    [Show full text]
  • ENVE: a Novel Computational Framework
    Varadan et al. Genome Medicine (2015) 7:69 DOI 10.1186/s13073-015-0192-9 METHOD Open Access ENVE: a novel computational framework characterizes copy-number mutational landscapes in colorectal cancers from African American patients Vinay Varadan1,2,7*†, Salendra Singh2, Arman Nosrati3, Lakshmeswari Ravi3, James Lutterbaugh3, Jill S. Barnholtz-Sloan1,2, Sanford D. Markowitz2,3,4,5, Joseph E. Willis2,4,5,6 and Kishore Guda1,2,4,7*† Abstract Reliable detection of somatic copy-number alterations (sCNAs) in tumors using whole-exome sequencing (WES) remains challenging owing to technical (inherent noise) and sample-associated variability in WES data. We present a novel computational framework, ENVE, which models inherent noise in any WES dataset, enabling robust detection of sCNAs across WES platforms. ENVE achieved high concordance with orthogonal sCNA assessments across two colorectal cancer (CRC) WES datasets, and consistently outperformed a best-in-class algorithm, Control-FREEC. We subsequently used ENVE to characterize global sCNA landscapes in African American CRCs, identifying genomic aberrations potentially associated with CRC pathogenesis in this population. ENVE is downloadable at https://github.com/ENVE-Tools/ENVE. Background comprehensively characterize genome-scale DNA alter- Human cancer is caused in part by structural changes ations in tumor tissues. In particular, whole-exome resulting in DNA copy-number alterations at distinct sequencing (WES) offers a cost-effective way of interro- locations in the tumor genome. Identification of such gating mutation and copy-number profiles within somatic copy-number alterations (sCNA) in tumor tis- protein-coding regions in the tumor genome. This has sues has contributed significantly to our understanding resulted in the increasing use of WES in both the re- of the pathogenesis and to the expansion of therapeutic search [8, 9] and clinical settings [10, 11].
    [Show full text]
  • Analyzing Public Opinion on COVID-19 Through Different Perspectives and Stages Yuqi Gao, Hang Hua and Jiebo Luo
    SIP (2021), vol. 10, e8, page 1 of 13 © The Author(s), 2021 published by Cambridge University Press in association with Asia Pacific Signal and Information Processing Association. This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike licence (http://creativecommons. org/licenses/by-nc-sa/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the same Creative Commons licence is included and the original work is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use. doi:10.1017/ATSIP.2021.5 selection from chinamm 2020 Analyzing public opinion on COVID-19 through different perspectives and stages yuqi gao, hang hua and jiebo luo In recent months, COVID-19 has become a global pandemic and had a huge impact on the world. People under different con- ditions have very different attitudes toward the epidemic. Due to the real-time and large-scale nature of social media, we can continuously obtain a massive amount of public opinion information related to the epidemic from social media. In particu- lar, researchers may ask questions such as “how is the public reacting to COVID-19 in China during different stages of the pandemic?”, “what factors affect the public opinion orientation in China?”, and so on. To answer such questions, we analyze the pandemic-related public opinion information on Weibo, China’s largest social media platform. Specifically, we have first collected a large amount of COVID-19-related public opinion microblogs. We then use a sentiment classifier to recognize and analyze different groups of users’ opinions.
    [Show full text]
  • A 26-Hour System of Highly Sensitive Whole Genome Sequencing for Emergency Management of Genetic Diseases Neil A
    Miller et al. Genome Medicine (2015) 7:100 DOI 10.1186/s13073-015-0221-8 METHOD Open Access A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases Neil A. Miller1†, Emily G. Farrow1,2,3,4†, Margaret Gibson1, Laurel K. Willig1,2,4, Greyson Twist1, Byunggil Yoo1, Tyler Marrs1, Shane Corder1, Lisa Krivohlavek1, Adam Walter1, Josh E. Petrikin1,2,4, Carol J. Saunders1,2,3,4, Isabelle Thiffault1,3, Sarah E. Soden1,2,4, Laurie D. Smith1,2,3,4, Darrell L. Dinwiddie5, Suzanne Herd1, Julie A. Cakici1, Severine Catreux6, Mike Ruehle6 and Stephen F. Kingsmore1,2,3,4,7* Abstract While the cost of whole genome sequencing (WGS) is approaching the realm of routine medical tests, it remains too tardy to help guide the management of many acute medical conditions. Rapid WGS is imperative in light of growing evidence of its utility in acute care, such as in diagnosis of genetic diseases in very ill infants, and genotype-guided choice of chemotherapy at cancer relapse. In such situations, delayed, empiric, or phenotype-based clinical decisions may meet with substantial morbidity or mortality. We previously described a rapid WGS method, STATseq, with a sensitivity of >96 % for nucleotide variants that allowed a provisional diagnosis of a genetic disease in 50 h. Here improvements in sequencing run time, read alignment, and variant calling are described that enable 26-h time to provisional molecular diagnosis with >99.5 % sensitivity and specificity of genotypes. STATseq appears to be an appropriate strategy for acutely ill patients with potentially actionable genetic diseases.
    [Show full text]
  • Exploration of Haplotype Research Consortium Imputation for Genome-Wide Association Studies in 20,032 Generation Scotland Participants Reka Nagy1, Thibaud S
    Nagy et al. Genome Medicine (2017) 9:23 DOI 10.1186/s13073-017-0414-4 RESEARCH Open Access Exploration of haplotype research consortium imputation for genome-wide association studies in 20,032 Generation Scotland participants Reka Nagy1, Thibaud S. Boutin1, Jonathan Marten1, Jennifer E. Huffman1, Shona M. Kerr1, Archie Campbell2, Louise Evenden3, Jude Gibson3, Carmen Amador1, David M. Howard4, Pau Navarro1, Andrew Morris5, Ian J. Deary6, Lynne J. Hocking7, Sandosh Padmanabhan8, Blair H. Smith9, Peter Joshi10, James F. Wilson10, Nicholas D. Hastie1, Alan F. Wright1, Andrew M. McIntosh4,6, David J. Porteous2,6, Chris S. Haley1, Veronique Vitart1 and Caroline Hayward1* Abstract Background: The Generation Scotland: Scottish Family Health Study (GS:SFHS) is a family-based population cohort with DNA, biological samples, socio-demographic, psychological and clinical data from approximately 24,000 adult volunteers across Scotland. Although data collection was cross-sectional, GS:SFHS became a prospective cohort due to of the ability to link to routine Electronic Health Record (EHR) data. Over 20,000 participants were selected for genotyping using a large genome-wide array. Methods: GS:SFHS was analysed using genome-wide association studies (GWAS) to test the effects of a large spectrum of variants, imputed using the Haplotype Research Consortium (HRC) dataset, on medically relevant traits measured directly or obtained from EHRs. The HRC dataset is the largest available haplotype reference panel for imputation of variants in populations of European ancestry and allows investigation of variants with low minor allele frequencies within the entire GS:SFHS genotyped cohort. Results: Genome-wide associations were run on 20,032 individuals using both genotyped and HRC imputed data.
    [Show full text]
  • Omic Personality: Implications of Stable
    Tabassum et al. Genome Medicine (2015) 7:88 DOI 10.1186/s13073-015-0209-4 RESEARCH Open Access Omic personality: implications of stable transcript and methylation profiles for personalized medicine Rubina Tabassum1,2, Ambily Sivadas1,3, Vartika Agrawal1,4, Haozheng Tian1, Dalia Arafat1 and Greg Gibson1* Abstract Background: Personalized medicine is predicated on the notion that individual biochemical and genomic profiles are relatively constant in times of good health and to some extent predictive of disease or therapeutic response. We report a pilot study quantifying gene expression and methylation profile consistency over time, addressing the reasons for individual uniqueness, and its relation to N = 1 phenotypes. Methods: Whole blood samples from four African American women, four Caucasian women, and four Caucasian men drawn from the Atlanta Center for Health Discovery and Well Being study at three successive 6-month intervals were profiled by RNA-Seq, miRNA-Seq, and Illumina Methylation 450 K arrays. Standard regression approaches were used to evaluate the proportion of variance for each type of omic measure among individuals, and to quantify correlations among measures and with clinical attributes related to wellness. Results: Longitudinal omic profiles were in general highly consistent over time, with an average of 67 % variance in transcript abundance, 42 % in CpG methylation level (but 88 % for the most differentiated CpG per gene), and 50 % in miRNA abundance among individuals, which are all comparable to 74 % variance among individuals for 74 clinical traits. One third of the variance could be attributed to differential blood cell type abundance, which was also fairly stable over time, and a lesser amount to expression quantitative trait loci (eQTL) effects.
    [Show full text]
  • Automatic Image Orientation Detection Via Confidence-Based Integration of Low-Level and Semantic Cues
    IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE, VOL. 27, NO. 5, MAY 2005 715 Automatic Image Orientation Detection via Confidence-Based Integration of Low-Level and Semantic Cues Jiebo Luo, Senior Member, IEEE, and Matthew Boutell, Student Member, IEEE Computer Society Abstract—Automatic image orientation detection for natural images is a useful, yet challenging research topic. Humans use scene context and semantic object recognition to identify the correct image orientation. However, it is difficult for a computer to perform the task in the same way because current object recognition algorithms are extremely limited in their scope and robustness. As a result, existing orientation detection methods were built upon low-level vision features such as spatial distributions of color and texture. Discrepant detection rates have been reported for these methods in the literature. We have developed a probabilistic approach to image orientation detection via confidence-based integration of low-level and semantic cues within a Bayesian framework. Our current accuracy is 90 percent for unconstrained consumer photos, impressive given the findings of a psychophysical study conducted recently. The proposed framework is an attempt to bridge the gap between computer and human vision systems and is applicable to other problems involving semantic scene content understanding. Index Terms—Image orientation, semantic cues, low-level cues, Bayesian networks, probabilistic inference, classification confidence. æ 1INTRODUCTION 1.1 Problem Statement 1.2 Recent Research ITH an explosion in the popularity of both online and Automatically determining the orientation of an arbitrary Woffline consumer image collections, organizing and image is a problem that only recently attracted attention in accessing these images become challenging tasks.
    [Show full text]
  • Downloaded from the CAVA Integration with Data Generated by Pre-NGS Methods Webpage [19]
    Münz et al. Genome Medicine (2015) 7:76 DOI 10.1186/s13073-015-0195-6 METHOD Open Access CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting Márton Münz1†, Elise Ruark2†, Anthony Renwick2, Emma Ramsay2, Matthew Clarke2, Shazia Mahamdallie2,3, Victoria Cloke3, Sheila Seal2,3, Ann Strydom2,3, Gerton Lunter1 and Nazneen Rahman2,3,4* Abstract Background: Next-generation sequencing (NGS) offers unprecedented opportunities to expand clinical genomics. It also presents challenges with respect to integration with data from other sequencing methods and historical data. Provision of consistent, clinically applicable variant annotation of NGS data has proved difficult, particularly of indels, an important variant class in clinical genomics. Annotation in relation to a reference genome sequence, the DNA strand of coding transcripts and potential alternative variant representations has not been well addressed. Here we present tools that address these challenges to provide rapid, standardized, clinically appropriate annotation of NGS data in line with existing clinical standards. Methods: We developed a clinical sequencing nomenclature (CSN), a fixed variant annotation consistent with the principles of the Human Genome Variation Society (HGVS) guidelines, optimized for automated variant annotation of NGS data. To deliver high-throughput CSN annotation we created CAVA (Clinical Annotation of VAriants), a fast, lightweight tool designed for easy incorporation into NGS pipelines. CAVA allows transcript specification, appropriately accommodates the strand of a gene transcript and flags variants with alternative annotations to facilitate clinical interpretation and comparison with other datasets. We evaluated CAVA in exome data and a clinical BRCA1/BRCA2 gene testing pipeline.
    [Show full text]
  • ECE Colloquium Speaker: Learning, Mining, and Interacting with Visual
    University of Rochester Department of Electrical and Computer Engineering Colloquium Learning, Mining, and Interacting with Visual Data on the Web Jiebo Luo Professor University of Rochester, Computer Science Wednesday, October 19th 11:00 AM – 12:00 PM Computer Studies Building (CSB) 209 Abstract: Increasingly rich and large-scale image related data are being posted to social network and media sharing websites. Researchers from multidisciplinary areas, including machine learning, computer vision, data mining, and human machine interaction, are developing methods for employing such multi-modality data for various applications. We present several recent advances in this arena of opportunities and challenges. First, we address the multi-modality feature issue by developing new machinery called Heterogeneous Feature Machines (HFM), which builds a kernel logistic regression model based on similarities that combine different features and distance metrics with group LASSO constraints. Its power is demonstrated across a wide variety of visual recognition tasks including scene, event, and action recognition. Second, we examine the recently popular data driven approach that has seemingly diminished the need for machine learning in favor of simply relying on large scale data. We believe it is important to address crucial machine learning issues, in particular cross- domain learning, in order to intelligently leverage large scale web data to solve problems such as searching personal images by keywords and recognizing events in personal videos. Next, we explore the global trends and sentiments that can be drawn by mining the sharing patterns of uploaded and downloaded social multimedia. We consider that each time an image or video is uploaded or shared, it constitutes an implicit yet trustworthy vote for (or against) the subject of the image.
    [Show full text]
  • Characterizing Biobank Organizations in the U.S.: Results from a National
    Henderson et al. Genome Medicine 2013, 5:3 http://genomemedicine.com/content/5/1/3 RESEARCH Open Access Characterizing biobank organizations in the U.S.: results from a national survey Gail E Henderson1*, R Jean Cadigan1, Teresa P Edwards2, Ian Conlon3, Anders G Nelson1, James P Evans4, Arlene M Davis1, Catherine Zimmer2,3 and Bryan J Weiner5 Abstract Background: Effective translational biomedical research hinges on the operation of ‘biobanks,’ repositories that assemble, store, and manage collections of human specimens and related data. Some are established intentionally to address particular research needs; many, however, have arisen opportunistically, in a variety of settings and with a variety of expectations regarding their functions and longevity. Despite their rising prominence, little is known about how biobanks are organized and function beyond simple classification systems (government, academia, industry). Methods: In 2012, we conducted the first national survey of biobanks in the U.S., collecting information on their origins, specimen collections, organizational structures, and market contexts and sustainability. From a list of 636 biobanks assembled through a multi-faceted search strategy, representatives from 456 U.S. biobanks were successfully recruited for a 30-minute online survey (72% response rate). Both closed and open-ended responses were analyzed using descriptive statistics. Results: While nearly two-thirds of biobanks were established within the last decade, 17% have been in existence for over 20 years. Fifty-three percent listed research on a particular disease as the most important reason for establishment; 29% listed research generally. Other reasons included response to a grant or gift, and intent to centralize, integrate, or harmonize existing research structures.
    [Show full text]